Detalles de la búsqueda
1.
Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients.
J Urol
; 209(5): 918-927, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36974724
2.
Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US.
Qual Life Res
; 32(11): 3209-3221, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37410340
3.
Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.
Prostate
; 82(11): 1107-1116, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35538298
4.
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC).
Invest New Drugs
; 39(1): 182-192, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32910338
5.
Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial.
Lancet Oncol
; 20(11): 1544-1555, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31563517
6.
Pegylated Interleukin-10: Clinical Development of an Immunoregulatory Cytokine for Use in Cancer Therapeutics.
Curr Oncol Rep
; 21(2): 19, 2019 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30790069
7.
Pain palliation measurement in cancer clinical trials: the US Food and Drug Administration perspective.
Cancer
; 120(5): 761-7, 2014 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24375398
8.
Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial.
Lancet Oncol
; 14(12): 1193-9, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24075621
9.
Balancing Hormone Therapy: Mitigating Adverse Effects of Androgen-Deprivation Therapy and Exploring Alternatives in Prostate Cancer Management.
Am Soc Clin Oncol Educ Book
; 44(3): e433126, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38788186
10.
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 30(8): 1488-1500, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38300720
11.
Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States.
Cancer Res Commun
; 4(1): 55-64, 2024 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38108490
12.
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer.
Cancer Epidemiol Biomarkers Prev
; 33(3): 419-425, 2024 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38189661
13.
Repetitively dosed docetaxel and ¹5³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer.
Cancer
; 119(17): 3186-94, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23765638
14.
Targeting bone physiology for the treatment of metastatic prostate cancer.
Clin Adv Hematol Oncol
; 11(3): 134-43, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23598981
15.
Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer.
J Immunother Precis Oncol
; 6(4): 162-169, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38143953
16.
First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC).
J Immunother Cancer
; 11(3)2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36948505
17.
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1).
J Immunother Cancer
; 11(3)2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36927527
18.
Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.
Eur Urol
; 83(1): 29-38, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36115772
19.
Therapeutic strategies for bone metastases and their clinical sequelae in prostate cancer.
Curr Treat Options Oncol
; 13(2): 174-88, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22528368
20.
Oligometastatic Squamous Cell Transformation From Metastatic Prostate Adenocarcinoma Treated With Systemic and Focal Therapy: A Case Report.
J Immunother Precis Oncol
; 5(3): 79-83, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36034583